SPOTLIGHT -
Dr. Schnabel Discusses the DCIS Recurrence Score
Dr. Freya Schnabel from NYU School of Medicine Discusses the DCIS Recurrence Score
Read More
Dr. Schnabel on Predicting Breast Cancer by Atypia Type
Dr. Freya Schnabel from NYU School of Medicine on Predicting Breast Cancer by Atypia Type
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
